Related Experiment Videos
Minimal-access parathyroid surgery using intraoperative parathyroid hormone assay
R A Sofferman1, J Standage, M E Tang
1Division of Otolaryngology-Head and Neck Surgery, The University of Vermont School of Medicine, USA.
The Laryngoscope
|October 20, 1998
Summary
Intraoperative parathyroid hormone (PTH) monitoring combined with preoperative imaging improves targeted tumor removal for primary hyperparathyroidism. This cost-effective method accurately guides surgery, ensuring successful patient outcomes.
Area of Science:
- Endocrinology
- Surgical Oncology
- Medical Imaging
Background:
- Primary hyperparathyroidism necessitates accurate localization for effective surgical treatment.
- Intraoperative parathyroid hormone (PTH) monitoring offers a dynamic assessment of surgical success.
Purpose of the Study:
- To review current preoperative localization imaging techniques for primary hyperparathyroidism.
- To demonstrate the applicability of these techniques with intraoperative PTH monitoring for targeted tumor removal.
Main Methods:
- Retrospective review of 40 patients undergoing parathyroid surgery.
- Utilized intraoperative PTH assay as the primary determinant of successful hyperparathyroid state correction.
- Discussed technology, cost analysis, and comparison with other management methods.
Main Results:
- All 40 patients achieved eucalcemia using intraoperative PTH monitoring and preoperative localization.
- Surgery focused on targeted pathology identified preoperatively.
- Approximately 50% of eligible patients underwent surgery under local anesthesia.
Conclusions:
- Intraoperative PTH assay is a valuable tool for primary and revision parathyroid surgery.
- This method is cost-effective, accurate, and can potentially reduce morbidity, especially in revision cases.